Rima Gerges Maalouf, a Massachusetts pharmacist, pleaded guilty in a New Hampshire drug case after authorities said prescription medications were misused during her time at a Lancaster pharmacy. The case now raises basic questions about trust inside patient care.
Investigators described the matter as tied to temporary pharmacy work in August 2024, while officials said the public needs confidence that prescribed medicine is handled safely. The fuller picture comes through court documents, company reports, and what prosecutors say happened.
What Authorities Said Happened at the Lancaster Pharmacy
Authorities said Rima Gerges Maalouf temporarily worked per diem at North Country Healthcare Pharmacy in Lancaster during August 2024. She was 60 and from Massachusetts, but the New Hampshire case focuses on what allegedly happened while she was filling a short-term role there.
Court documents said Gerges Maalouf was the only pharmacist on duty from August 6 to 9, 2024. During that stretch, more than a dozen different medication types were later found missing, which made the staffing timeline especially important to investigators.
The missing medications included stimulants and many depressants in the benzodiazepine family of drugs, according to authorities. That detail matters because these are controlled medicines patients depend on, and any missing supply inside a pharmacy raises immediate safety and accountability concerns.
How the Investigation Developed
Court documents indicate security camera footage showed Gerges Maalouf opening bottles and ingesting some of the medication while she was working. For investigators, that mattered because it tied the concern to conduct inside the pharmacy, not only inventory numbers discovered afterward.
The possible misuse was reported to the DEA by Maxor National Pharmacy Services (now VytlOne), the company that owned and managed the pharmacy. The report came shortly after the Lancaster concerns surfaced publicly there.
Maxor also fired Gerges Maalouf for cause before her court case was finished, according to the report. That step is important because the company treated the pharmacy findings as serious enough for immediate employment action, even before sentencing or final court closure.
Why Officials Said the Case Put Patients at Risk
According to the U.S. Attorney’s Office in New Hampshire, Gerges Maalouf pleaded guilty Monday to misusing medications at the Lancaster pharmacy. She faces up to 4 years in prison, showing prosecutors treated the pharmacy conduct as more than a workplace rule violation.
U.S. Attorney Erin Creegan said the defendant, a licensed pharmacist, emptied medication from pills prescribed for others and took them herself. Creegan also said some patients received pills after medication had already been drained out, creating a direct safety risk.
New Hampshire officials said they will keep prosecuting crimes that “erode public trust.” Creegan called the conduct “very dangerous” because patients depend on those treatments for health and safety, which is exactly why pharmacy access must be handled with care.
Endnote
Debate around this New Hampshire case sits with how prescription drug misuse looks different when the accused person is a licensed pharmacist. Authorities said patients may have received drained pills, which turns workplace misconduct into a patient safety issue, not just missing inventory.
Next chapters should focus on sentencing, pharmacy oversight, and the Vermont records tied to a similar missing medication pattern at a Maxor-managed pharmacy in Colchester. Gerges Maalouf faces up to 4 years, while prosecutors keep the public trust argument central.